Spanish Health Ministry Seeks Public Opinion on Tobacco Regulations

Regulations by 2FIRSTS.ai
Apr.09.2024
Spanish Health Ministry Seeks Public Opinion on Tobacco Regulations
Spanish Health Ministry seeks public input on Royal Decree draft, aiming to further tobacco regulation following nationwide smoking ban.

According to Spanish media La Voz de Galicia on April 8th, the Spanish Ministry of Health is officially seeking public opinions on a draft royal decree regarding plain packaging and the prohibition of additives in tobacco and related products. The aim is to evaluate and improve this legislative reform proposal. This is the first legislative measure taken following the implementation of the comprehensive smoking ban plan last Friday (April 5th).

 

Health Minister Monica Garcia emphasized at a social health breakfast organized by the European News Agency, "The plain packaging policy is effective, as it not only eliminates the attractiveness of tobacco packaging as advertising, but also helps to inspire people to quit smoking." Currently, many countries such as Australia, France, Norway, and Denmark have fully implemented plain packaging policies and have achieved significant results.

 

From now (April 8th) until April 23rd, all Spanish citizens, organizations and associations are free to express their opinions on this policy. The proposal will reform the Royal Decree 579/2017 that regulates various aspects of tobacco manufacturing, sales and commercialization.

 

The bill argues that "health protection" necessitates "emergency updates" to regulations in order to address issues such as the steady increase in tobacco and related product consumption and the exposure of ordinary people, especially young people, to new forms of nicotine consumption. It claims that current regulations are unable to keep up with the supply of these new products on the market, losing effectiveness in combining health warnings while maintaining product appeal. More importantly, there is a regulatory gap for nicotine-free e-cigarettes and herbal smoking products.

 

Therefore, the legislation aims to introduce many improvements within existing regulations, such as implementing plain packaging and "properly categorizing emerging products" to enhance labeling and packaging.

 

Additionally, this includes banning the use of tobacco-flavored additives in tobacco and related products, as well as additives and ingredients that distort health regulations' objectives or may be more appealing to consumers.

 

This is the first initiative launched by the Spanish Ministry of Health since the release of the Comprehensive Tobacco Addiction Prevention Plan (PIT) for 2024-2027. The plan was approved last Friday (April 5th) by the entire Interregional Health Committee after being reviewed.

 

Minister of Health Monica Garcia stated:

 

I want to express my deep gratitude to all the local regions that are working towards achieving this important consensus. For those like the skeptics in 2005 who predicted the first tobacco act would have a 'doomsday' effect and ultimately failed, as well as those 'lobby groups with commercial interests,' they will hit a wall if they try to influence this department on anything related to protecting the health of our citizens.

 

In addition to other measures, some of the initiatives included in the plan will harmonize regulations on tobacco-related products with traditional tobacco regulations: The Ministry of Finance has revised tobacco taxes to bring Spain closer to its neighboring countries, with hopes that this increase in revenue can be used to advance public health policies. At the same time, it also includes expanding smoke-free zones.

 

Another goal of the program is to promote research on tobacco and its effects, strengthening evidence on the impacts of new tobacco products. The minister criticized those who were against the plan from the start, had apocalyptic ideas, and made similar statements as early as 2005 and 2010.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Alimentation Couche-Tard said U.S. same-store sales in its “other nicotine products” category grew at a double-digit rate in the first quarter of fiscal 2027, led by nicotine pouches, while overall U.S. same-store merchandise revenues increased 1.7%. The company also said its Canadian nicotine business continued to face regulatory pressure and illicit-market headwinds. The U.S. performance coincides with Couche-Tard's participation in efforts to reopen Canadian convenience-store access to authorized nicotine pouches, though the company has not established a direct causal link between the two.
Sep.14
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
SMOORE’s DOJO by VAPORESSO to Launch New Global Brand Identity on September 1
SMOORE’s DOJO by VAPORESSO to Launch New Global Brand Identity on September 1
According to recent LinkedIn posts from people at VAPORESSO, SMOORE and a German distribution partner, vape brand DOJO will begin rolling out a new global brand identity on September 1, 2026, led by a redesigned handwritten logo. The new visual system will be gradually applied across product packaging, marketing materials and digital assets over the following months. Fabio Corsaro, Head of Marketing and Purchasing at MG Wesel GmbH, said the rebrand was related to trademark issues, but that explanation has not been publicly confirmed by DOJO, VAPORESSO or SMOORE. DOJO is currently promoting its Blast X product in Germany.
Aug.31
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company has begun selling four flavored Vuse Pro pods — Peach, Berry, Watermelon and Fresh Mint — in Ohio and selected other U.S. markets. According to the Vuse U.S. FAQ, Vuse Pro contains approximately 5.0% nicotine by weight, and Vuse Pro pre-filled pods are intended for use with Vuse Alto devices. Reynolds told 2Firsts that product labeling lists an e-liquid capacity of 2.0 mL per pod. The Vuse Alto Power Unit received FDA marketing authorization in 2024, while the new Vuse Pro pods themselves have not received marketing granted orders. The rollout follows the FDA’s May 2026 revision of enforcement priorities for certain unauthorized vaping products with qualifying pending applications.
BAT
Sep.10
Product | JTI Philippines Expands Nordic Spirit Nicotine Pouch Portfolio With Dark Pop and Red Frost
Product | JTI Philippines Expands Nordic Spirit Nicotine Pouch Portfolio With Dark Pop and Red Frost
JTI Philippines has expanded the Nordic Spirit nicotine pouch portfolio in the Philippines with two new variants, Dark Pop and Red Frost. Both products maintain the brand’s tobacco-free nicotine pouch positioning, with Dark Pop featuring a fizzy cola profile with citrus and sweet notes, while Red Frost combines cool mint with sweet red berry flavors. The two variants are now available through Philippine online retail channels.
Aug.18
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08